nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP2C8—Levothyroxine—hypothyroidism	0.224	0.42	CbGbCtD
Raloxifene—CYP2C8—Liotrix—hypothyroidism	0.219	0.41	CbGbCtD
Raloxifene—CYP3A4—Levothyroxine—hypothyroidism	0.0909	0.17	CbGbCtD
Raloxifene—ESR2—seminiferous tubule of testis—hypothyroidism	0.0392	0.142	CbGeAlD
Raloxifene—CYP19A1—corpus luteum—hypothyroidism	0.0364	0.132	CbGeAlD
Raloxifene—CYP19A1—seminiferous tubule of testis—hypothyroidism	0.0309	0.112	CbGeAlD
Raloxifene—ESR2—Nuclear Receptors—THRA—hypothyroidism	0.007	0.0909	CbGpPWpGaD
Raloxifene—EBP—liver—hypothyroidism	0.00649	0.0235	CbGeAlD
Raloxifene—CYP3A4—urine—hypothyroidism	0.00578	0.021	CbGeAlD
Raloxifene—ESR2—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00553	0.0718	CbGpPWpGaD
Raloxifene—Tenderness—Liotrix—hypothyroidism	0.00536	0.0472	CcSEcCtD
Raloxifene—ESR2—Nuclear Receptors—THRB—hypothyroidism	0.00451	0.0586	CbGpPWpGaD
Raloxifene—ESR2—heart—hypothyroidism	0.00387	0.014	CbGeAlD
Raloxifene—AOX1—adrenal cortex—hypothyroidism	0.00386	0.014	CbGeAlD
Raloxifene—AOX1—heart—hypothyroidism	0.00373	0.0135	CbGeAlD
Raloxifene—ESR2—cardiovascular system—hypothyroidism	0.00366	0.0133	CbGeAlD
Raloxifene—Body temperature increased—Liothyronine—hypothyroidism	0.00365	0.0322	CcSEcCtD
Raloxifene—ESR2—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00356	0.0463	CbGpPWpGaD
Raloxifene—ESR1—Nuclear Receptors—THRA—hypothyroidism	0.00353	0.0458	CbGpPWpGaD
Raloxifene—Cerebrovascular accident—Liotrix—hypothyroidism	0.00346	0.0305	CcSEcCtD
Raloxifene—Sweating—Levothyroxine—hypothyroidism	0.00341	0.03	CcSEcCtD
Raloxifene—Sweating—Dextrothyroxine—hypothyroidism	0.00341	0.03	CcSEcCtD
Raloxifene—ESR2—gonad—hypothyroidism	0.00332	0.012	CbGeAlD
Raloxifene—ESR2—pituitary gland—hypothyroidism	0.00324	0.0117	CbGeAlD
Raloxifene—AOX1—gonad—hypothyroidism	0.00319	0.0116	CbGeAlD
Raloxifene—AOX1—pituitary gland—hypothyroidism	0.00312	0.0113	CbGeAlD
Raloxifene—SIGMAR1—adrenal cortex—hypothyroidism	0.0031	0.0113	CbGeAlD
Raloxifene—HTR2B—adrenal cortex—hypothyroidism	0.0031	0.0112	CbGeAlD
Raloxifene—SIGMAR1—heart—hypothyroidism	0.003	0.0109	CbGeAlD
Raloxifene—HTR2B—heart—hypothyroidism	0.00299	0.0109	CbGeAlD
Raloxifene—Flushing—Dextrothyroxine—hypothyroidism	0.00296	0.0261	CcSEcCtD
Raloxifene—Flushing—Levothyroxine—hypothyroidism	0.00296	0.0261	CcSEcCtD
Raloxifene—ESR2—adrenal gland—hypothyroidism	0.00289	0.0105	CbGeAlD
Raloxifene—ESR2—blood—hypothyroidism	0.00289	0.0105	CbGeAlD
Raloxifene—HTR2B—cardiovascular system—hypothyroidism	0.00283	0.0102	CbGeAlD
Raloxifene—Bronchitis—Liotrix—hypothyroidism	0.00282	0.0249	CcSEcCtD
Raloxifene—ESR2—thyroid gland—hypothyroidism	0.00279	0.0101	CbGeAlD
Raloxifene—ESR1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00279	0.0362	CbGpPWpGaD
Raloxifene—AOX1—adrenal gland—hypothyroidism	0.00278	0.0101	CbGeAlD
Raloxifene—ESR2—female gonad—hypothyroidism	0.0027	0.00978	CbGeAlD
Raloxifene—AOX1—thyroid gland—hypothyroidism	0.00269	0.00974	CbGeAlD
Raloxifene—ESR1—heart—hypothyroidism	0.00265	0.00962	CbGeAlD
Raloxifene—CYP19A1—gonad—hypothyroidism	0.00261	0.00948	CbGeAlD
Raloxifene—AOX1—female gonad—hypothyroidism	0.0026	0.00941	CbGeAlD
Raloxifene—SIGMAR1—pituitary gland—hypothyroidism	0.00251	0.00909	CbGeAlD
Raloxifene—Sweating—Liotrix—hypothyroidism	0.00251	0.0221	CcSEcCtD
Raloxifene—ESR1—cardiovascular system—hypothyroidism	0.0025	0.00908	CbGeAlD
Raloxifene—ESR2—testis—hypothyroidism	0.00239	0.00867	CbGeAlD
Raloxifene—Arthralgia—Levothyroxine—hypothyroidism	0.00236	0.0208	CcSEcCtD
Raloxifene—Arthralgia—Dextrothyroxine—hypothyroidism	0.00236	0.0208	CcSEcCtD
Raloxifene—Hypoaesthesia—Liotrix—hypothyroidism	0.00233	0.0206	CcSEcCtD
Raloxifene—AOX1—testis—hypothyroidism	0.0023	0.00835	CbGeAlD
Raloxifene—CYP19A1—adrenal gland—hypothyroidism	0.00228	0.00826	CbGeAlD
Raloxifene—CYP19A1—blood—hypothyroidism	0.00228	0.00826	CbGeAlD
Raloxifene—ESR1—Nuclear Receptors—THRB—hypothyroidism	0.00227	0.0295	CbGpPWpGaD
Raloxifene—ESR1—gonad—hypothyroidism	0.00227	0.00824	CbGeAlD
Raloxifene—ESR2—liver—hypothyroidism	0.00226	0.0082	CbGeAlD
Raloxifene—ESR2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00226	0.0294	CbGpPWpGaD
Raloxifene—SIGMAR1—adrenal gland—hypothyroidism	0.00224	0.00812	CbGeAlD
Raloxifene—SIGMAR1—blood—hypothyroidism	0.00224	0.00812	CbGeAlD
Raloxifene—HTR2B—adrenal gland—hypothyroidism	0.00224	0.00811	CbGeAlD
Raloxifene—HTR2B—blood—hypothyroidism	0.00223	0.0081	CbGeAlD
Raloxifene—Shock—Dextrothyroxine—hypothyroidism	0.00223	0.0197	CcSEcCtD
Raloxifene—Shock—Levothyroxine—hypothyroidism	0.00223	0.0197	CcSEcCtD
Raloxifene—ESR1—pituitary gland—hypothyroidism	0.00222	0.00804	CbGeAlD
Raloxifene—ESR2—cerebellum—hypothyroidism	0.00221	0.00801	CbGeAlD
Raloxifene—CYP19A1—thyroid gland—hypothyroidism	0.0022	0.00797	CbGeAlD
Raloxifene—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00219	0.0193	CcSEcCtD
Raloxifene—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00219	0.0193	CcSEcCtD
Raloxifene—Flushing—Liotrix—hypothyroidism	0.00218	0.0192	CcSEcCtD
Raloxifene—AOX1—liver—hypothyroidism	0.00218	0.00789	CbGeAlD
Raloxifene—SIGMAR1—thyroid gland—hypothyroidism	0.00216	0.00784	CbGeAlD
Raloxifene—HTR2B—thyroid gland—hypothyroidism	0.00216	0.00782	CbGeAlD
Raloxifene—AOX1—cerebellum—hypothyroidism	0.00213	0.00771	CbGeAlD
Raloxifene—CYP19A1—female gonad—hypothyroidism	0.00212	0.0077	CbGeAlD
Raloxifene—SIGMAR1—female gonad—hypothyroidism	0.00209	0.00757	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00206	0.0182	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00206	0.0182	CcSEcCtD
Raloxifene—Insomnia—Levothyroxine—hypothyroidism	0.00205	0.0181	CcSEcCtD
Raloxifene—Insomnia—Dextrothyroxine—hypothyroidism	0.00205	0.0181	CcSEcCtD
Raloxifene—CYP2B6—adrenal cortex—hypothyroidism	0.00203	0.00735	CbGeAlD
Raloxifene—Flatulence—Liotrix—hypothyroidism	0.00201	0.0177	CcSEcCtD
Raloxifene—ESR1—adrenal gland—hypothyroidism	0.00198	0.00718	CbGeAlD
Raloxifene—ESR1—blood—hypothyroidism	0.00198	0.00718	CbGeAlD
Raloxifene—CYP2B6—heart—hypothyroidism	0.00196	0.00711	CbGeAlD
Raloxifene—ESR1—thyroid gland—hypothyroidism	0.00191	0.00693	CbGeAlD
Raloxifene—CYP19A1—testis—hypothyroidism	0.00188	0.00683	CbGeAlD
Raloxifene—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00185	0.0163	CcSEcCtD
Raloxifene—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00185	0.0163	CcSEcCtD
Raloxifene—SIGMAR1—testis—hypothyroidism	0.00185	0.00672	CbGeAlD
Raloxifene—CYP2B6—cardiovascular system—hypothyroidism	0.00185	0.00671	CbGeAlD
Raloxifene—ESR1—female gonad—hypothyroidism	0.00185	0.0067	CbGeAlD
Raloxifene—Syncope—Liotrix—hypothyroidism	0.00183	0.0162	CcSEcCtD
Raloxifene—CYP2C8—pituitary gland—hypothyroidism	0.00183	0.00662	CbGeAlD
Raloxifene—ESR1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0018	0.0233	CbGpPWpGaD
Raloxifene—Loss of consciousness—Liotrix—hypothyroidism	0.0018	0.0158	CcSEcCtD
Raloxifene—Abdominal pain—Levothyroxine—hypothyroidism	0.00179	0.0158	CcSEcCtD
Raloxifene—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00179	0.0158	CcSEcCtD
Raloxifene—Body temperature increased—Levothyroxine—hypothyroidism	0.00179	0.0158	CcSEcCtD
Raloxifene—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00179	0.0158	CcSEcCtD
Raloxifene—CYP19A1—liver—hypothyroidism	0.00178	0.00646	CbGeAlD
Raloxifene—SIGMAR1—liver—hypothyroidism	0.00175	0.00635	CbGeAlD
Raloxifene—Arthralgia—Liotrix—hypothyroidism	0.00174	0.0153	CcSEcCtD
Raloxifene—Chest pain—Liotrix—hypothyroidism	0.00174	0.0153	CcSEcCtD
Raloxifene—SIGMAR1—cerebellum—hypothyroidism	0.00171	0.0062	CbGeAlD
Raloxifene—CYP2B6—gonad—hypothyroidism	0.00168	0.00609	CbGeAlD
Raloxifene—Infection—Liotrix—hypothyroidism	0.00166	0.0146	CcSEcCtD
Raloxifene—Shock—Liotrix—hypothyroidism	0.00164	0.0145	CcSEcCtD
Raloxifene—ESR1—testis—hypothyroidism	0.00164	0.00594	CbGeAlD
Raloxifene—CYP2C8—blood—hypothyroidism	0.00163	0.00591	CbGeAlD
Raloxifene—Hyperhidrosis—Liotrix—hypothyroidism	0.00161	0.0142	CcSEcCtD
Raloxifene—Diarrhoea—Levothyroxine—hypothyroidism	0.00155	0.0137	CcSEcCtD
Raloxifene—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00155	0.0137	CcSEcCtD
Raloxifene—ESR1—liver—hypothyroidism	0.00155	0.00561	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00152	0.0134	CcSEcCtD
Raloxifene—ESR1—cerebellum—hypothyroidism	0.00151	0.00548	CbGeAlD
Raloxifene—Insomnia—Liotrix—hypothyroidism	0.00151	0.0133	CcSEcCtD
Raloxifene—ESR2—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00148	0.0193	CbGpPWpGaD
Raloxifene—CYP2B6—adrenal gland—hypothyroidism	0.00146	0.00531	CbGeAlD
Raloxifene—CYP2B6—blood—hypothyroidism	0.00146	0.00531	CbGeAlD
Raloxifene—ESR2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00146	0.0189	CbGpPWpGaD
Raloxifene—Vomiting—Levothyroxine—hypothyroidism	0.00144	0.0127	CcSEcCtD
Raloxifene—Vomiting—Dextrothyroxine—hypothyroidism	0.00144	0.0127	CcSEcCtD
Raloxifene—Rash—Levothyroxine—hypothyroidism	0.00143	0.0126	CcSEcCtD
Raloxifene—Rash—Dextrothyroxine—hypothyroidism	0.00143	0.0126	CcSEcCtD
Raloxifene—Dermatitis—Dextrothyroxine—hypothyroidism	0.00143	0.0126	CcSEcCtD
Raloxifene—Dermatitis—Levothyroxine—hypothyroidism	0.00143	0.0126	CcSEcCtD
Raloxifene—Headache—Levothyroxine—hypothyroidism	0.00142	0.0125	CcSEcCtD
Raloxifene—Headache—Dextrothyroxine—hypothyroidism	0.00142	0.0125	CcSEcCtD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00137	0.0178	CbGpPWpGaD
Raloxifene—Gastrointestinal pain—Liotrix—hypothyroidism	0.00136	0.012	CcSEcCtD
Raloxifene—CYP2C8—testis—hypothyroidism	0.00135	0.00489	CbGeAlD
Raloxifene—Nausea—Levothyroxine—hypothyroidism	0.00135	0.0119	CcSEcCtD
Raloxifene—Nausea—Dextrothyroxine—hypothyroidism	0.00135	0.0119	CcSEcCtD
Raloxifene—ESR2—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00133	0.0172	CbGpPWpGaD
Raloxifene—Body temperature increased—Liotrix—hypothyroidism	0.00132	0.0116	CcSEcCtD
Raloxifene—Abdominal pain—Liotrix—hypothyroidism	0.00132	0.0116	CcSEcCtD
Raloxifene—CYP2C8—liver—hypothyroidism	0.00128	0.00463	CbGeAlD
Raloxifene—CYP2B6—testis—hypothyroidism	0.00121	0.00439	CbGeAlD
Raloxifene—CYP2B6—liver—hypothyroidism	0.00114	0.00415	CbGeAlD
Raloxifene—Diarrhoea—Liotrix—hypothyroidism	0.00114	0.0101	CcSEcCtD
Raloxifene—CYP3A4—blood—hypothyroidism	0.0011	0.00401	CbGeAlD
Raloxifene—Dizziness—Liotrix—hypothyroidism	0.0011	0.00972	CcSEcCtD
Raloxifene—ESR2—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00108	0.014	CbGpPWpGaD
Raloxifene—Vomiting—Liotrix—hypothyroidism	0.00106	0.00935	CcSEcCtD
Raloxifene—Rash—Liotrix—hypothyroidism	0.00105	0.00927	CcSEcCtD
Raloxifene—Dermatitis—Liotrix—hypothyroidism	0.00105	0.00926	CcSEcCtD
Raloxifene—Headache—Liotrix—hypothyroidism	0.00104	0.00921	CcSEcCtD
Raloxifene—CYP19A1—Endogenous sterols—POMC—hypothyroidism	0.001	0.013	CbGpPWpGaD
Raloxifene—ESR1—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.000995	0.0129	CbGpPWpGaD
Raloxifene—Nausea—Liotrix—hypothyroidism	0.00099	0.00873	CcSEcCtD
Raloxifene—ESR2—Generic Transcription Pathway—THRA—hypothyroidism	0.000955	0.0124	CbGpPWpGaD
Raloxifene—CYP3A4—liver—hypothyroidism	0.000864	0.00313	CbGeAlD
Raloxifene—EBP—Metabolism—IYD—hypothyroidism	0.000827	0.0107	CbGpPWpGaD
Raloxifene—HTR6—G alpha (s) signalling events—TSHB—hypothyroidism	0.000784	0.0102	CbGpPWpGaD
Raloxifene—HTR6—G alpha (s) signalling events—TSHR—hypothyroidism	0.000784	0.0102	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.000752	0.00977	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.000747	0.00971	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—ZNF764—hypothyroidism	0.000714	0.00927	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ATP5O—hypothyroidism	0.000703	0.00913	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000681	0.00884	CbGpPWpGaD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.000669	0.00869	CbGpPWpGaD
Raloxifene—EBP—Metabolism—TPO—hypothyroidism	0.000661	0.00858	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—THRB—hypothyroidism	0.000616	0.00799	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000612	0.00795	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00058	0.00753	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—TRH—hypothyroidism	0.000578	0.00751	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.000544	0.00707	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000517	0.00672	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—THRA—hypothyroidism	0.000482	0.00626	CbGpPWpGaD
Raloxifene—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000466	0.00606	CbGpPWpGaD
Raloxifene—HTR6—G alpha (s) signalling events—AVP—hypothyroidism	0.000462	0.006	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—THRA—hypothyroidism	0.00046	0.00597	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—IYD—hypothyroidism	0.000458	0.00595	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000419	0.00545	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ATP5O—hypothyroidism	0.000389	0.00506	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000383	0.00497	CbGpPWpGaD
Raloxifene—CYP19A1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000378	0.00491	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000374	0.00486	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000374	0.00486	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—TPO—hypothyroidism	0.000366	0.00476	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—ZNF764—hypothyroidism	0.00036	0.00467	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.000343	0.00446	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000341	0.00443	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000341	0.00443	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PRL—hypothyroidism	0.000335	0.00435	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NKX2-5—hypothyroidism	0.000328	0.00426	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—TRH—hypothyroidism	0.000319	0.00415	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000315	0.0041	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—THRB—hypothyroidism	0.00031	0.00403	CbGpPWpGaD
Raloxifene—HTR6—G alpha (s) signalling events—POMC—hypothyroidism	0.000307	0.00399	CbGpPWpGaD
Raloxifene—EBP—Metabolism—TSHB—hypothyroidism	0.000306	0.00397	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—AVP—hypothyroidism	0.000304	0.00394	CbGpPWpGaD
Raloxifene—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000299	0.00389	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—THRB—hypothyroidism	0.000296	0.00385	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—TRH—hypothyroidism	0.000292	0.00379	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—TSHR—hypothyroidism	0.000285	0.0037	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—TSHB—hypothyroidism	0.000285	0.0037	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PIK3C2A—hypothyroidism	0.000273	0.00354	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000272	0.00353	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000269	0.00349	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—TSHB—hypothyroidism	0.00026	0.00338	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—TSHR—hypothyroidism	0.00026	0.00338	CbGpPWpGaD
Raloxifene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000253	0.00329	CbGpPWpGaD
Raloxifene—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000243	0.00315	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—IYD—hypothyroidism	0.000237	0.00308	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—THRA—hypothyroidism	0.000232	0.00301	CbGpPWpGaD
Raloxifene—EBP—Metabolism—SLC5A5—hypothyroidism	0.000229	0.00297	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00022	0.00286	CbGpPWpGaD
Raloxifene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000206	0.00267	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ATP5O—hypothyroidism	0.000201	0.00262	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000201	0.00261	CbGpPWpGaD
Raloxifene—CYP19A1—Biological oxidations—POMC—hypothyroidism	0.000201	0.00261	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TPO—hypothyroidism	0.000189	0.00246	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—TRH—hypothyroidism	0.000181	0.00234	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000175	0.00228	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—TSHB—hypothyroidism	0.00017	0.0022	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—AVP—hypothyroidism	0.000168	0.00218	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NKX2-5—hypothyroidism	0.000165	0.00215	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—TRH—hypothyroidism	0.000165	0.00214	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TRH—hypothyroidism	0.000164	0.00213	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—TSHB—hypothyroidism	0.000161	0.00209	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—TSHR—hypothyroidism	0.000161	0.00209	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000159	0.00207	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—AVP—hypothyroidism	0.000153	0.00199	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—IYD—hypothyroidism	0.000152	0.00198	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3C2A—hypothyroidism	0.000151	0.00196	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TRH—hypothyroidism	0.00015	0.00194	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—THRB—hypothyroidism	0.000149	0.00194	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—TSHR—hypothyroidism	0.000147	0.00191	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—TSHB—hypothyroidism	0.000147	0.00191	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000146	0.0019	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TSHB—hypothyroidism	0.000146	0.0019	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TSHR—hypothyroidism	0.000146	0.0019	CbGpPWpGaD
Raloxifene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000136	0.00177	CbGpPWpGaD
Raloxifene—AOX1—Disease—PRL—hypothyroidism	0.000134	0.00174	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000134	0.00174	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TSHB—hypothyroidism	0.000133	0.00173	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TSHR—hypothyroidism	0.000133	0.00173	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ATP5O—hypothyroidism	0.000129	0.00168	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—POMC—hypothyroidism	0.000129	0.00167	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—IYD—hypothyroidism	0.000129	0.00167	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—SLC5A5—hypothyroidism	0.000127	0.00165	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TPO—hypothyroidism	0.000122	0.00158	CbGpPWpGaD
Raloxifene—EBP—Metabolism—POMC—hypothyroidism	0.00012	0.00156	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CLTC—hypothyroidism	0.000112	0.00146	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—POMC—hypothyroidism	0.000112	0.00145	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00011	0.00143	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ATP5O—hypothyroidism	0.00011	0.00142	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—POMC—hypothyroidism	0.000109	0.00142	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TPO—hypothyroidism	0.000103	0.00134	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CLTC—hypothyroidism	0.000102	0.00133	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—POMC—hypothyroidism	0.000102	0.00132	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—VAV3—hypothyroidism	9.84e-05	0.00128	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TRH—hypothyroidism	9.68e-05	0.00126	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.54e-05	0.00124	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AVP—hypothyroidism	9.48e-05	0.00123	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—VAV3—hypothyroidism	8.98e-05	0.00117	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—VAV3—hypothyroidism	8.94e-05	0.00116	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TRH—hypothyroidism	8.84e-05	0.00115	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TSHB—hypothyroidism	8.77e-05	0.00114	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AVP—hypothyroidism	8.66e-05	0.00112	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TSHB—hypothyroidism	8.63e-05	0.00112	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TSHR—hypothyroidism	8.63e-05	0.00112	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AVP—hypothyroidism	8.61e-05	0.00112	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CLTC—hypothyroidism	8.52e-05	0.00111	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—VAV3—hypothyroidism	8.16e-05	0.00106	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TSHB—hypothyroidism	7.88e-05	0.00102	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TSHR—hypothyroidism	7.88e-05	0.00102	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AVP—hypothyroidism	7.86e-05	0.00102	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3C2A—hypothyroidism	7.81e-05	0.00101	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.71e-05	0.001	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SH2B3—hypothyroidism	7.69e-05	0.000999	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TRH—hypothyroidism	7.36e-05	0.000956	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SH2B3—hypothyroidism	7.02e-05	0.000912	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—IYD—hypothyroidism	6.91e-05	0.000898	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—POMC—hypothyroidism	6.64e-05	0.000862	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—SLC5A5—hypothyroidism	6.56e-05	0.000852	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TSHB—hypothyroidism	6.56e-05	0.000852	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TSHR—hypothyroidism	6.56e-05	0.000852	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—POMC—hypothyroidism	6.3e-05	0.000818	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.88e-05	0.000763	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.86e-05	0.000761	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SH2B3—hypothyroidism	5.85e-05	0.00076	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—POMC—hypothyroidism	5.75e-05	0.000747	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—POMC—hypothyroidism	5.72e-05	0.000743	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PRL—hypothyroidism	5.71e-05	0.000741	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TSHB—hypothyroidism	5.63e-05	0.000731	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TPO—hypothyroidism	5.53e-05	0.000718	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VAV3—hypothyroidism	5.28e-05	0.000686	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—POMC—hypothyroidism	5.22e-05	0.000678	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PRL—hypothyroidism	5.21e-05	0.000677	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AVP—hypothyroidism	5.09e-05	0.000661	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	5.02e-05	0.000652	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VAV3—hypothyroidism	4.82e-05	0.000626	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TSHB—hypothyroidism	4.77e-05	0.000619	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AVP—hypothyroidism	4.64e-05	0.000603	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PRL—hypothyroidism	4.34e-05	0.000564	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	4.25e-05	0.000552	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—SLC5A5—hypothyroidism	4.21e-05	0.000547	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.19e-05	0.000544	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VAV3—hypothyroidism	4.01e-05	0.000521	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AVP—hypothyroidism	3.87e-05	0.000502	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—SLC5A5—hypothyroidism	3.57e-05	0.000463	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—POMC—hypothyroidism	3.43e-05	0.000446	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—POMC—hypothyroidism	3.38e-05	0.000439	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1—hypothyroidism	3.25e-05	0.000422	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—POMC—hypothyroidism	3.09e-05	0.000401	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1—hypothyroidism	2.97e-05	0.000385	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—POMC—hypothyroidism	2.57e-05	0.000334	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TSHB—hypothyroidism	2.56e-05	0.000332	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1—hypothyroidism	2.47e-05	0.000321	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.28e-05	0.000296	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—POMC—hypothyroidism	2.21e-05	0.000286	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.92e-05	0.000249	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—POMC—hypothyroidism	1.87e-05	0.000242	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—POMC—hypothyroidism	1e-05	0.00013	CbGpPWpGaD
